[8-K] DENTSPLY SIRONA Inc. Reports Material Event
DENTSPLY SIRONA Inc. announced on September 8, 2025 that it completed its previously disclosed review of strategic alternatives for its Wellspect Healthcare business and the Board determined that Wellspect will remain within the Company’s portfolio. The Company furnished a related press release as Exhibit 99.1 to this Current Report on Form 8-K. The filing notes the exhibit is furnished (not "filed") and therefore is not incorporated by reference into other Securities Act or Exchange Act filings absent specific reference. No financial statements, transaction terms, or forward-looking guidance are included in the provided text.
DENTSPLY SIRONA Inc. ha annunciato l'8 settembre 2025 di aver completato la revisione delle alternative strategiche per la sua divisione Wellspect Healthcare e il Consiglio ha deciso che Wellspect rimarrà nel portafoglio della Società. La Società ha fornito un comunicato stampa correlato come Allegato 99.1 a questo Current Report sul Modulo 8-K. Nel documento si precisa che l'allegato è "fornito" (non "depositato") e quindi non è incorporato per riferimento in altri documenti ai sensi del Securities Act o dell'Exchange Act, salvo riferimento specifico. Il testo fornito non contiene bilanci, termini della transazione né indicazioni prospettiche.
DENTSPLY SIRONA Inc. anunció el 8 de septiembre de 2025 que completó la revisión previamente comunicada de alternativas estratégicas para su negocio Wellspect Healthcare y la Junta determinó que Wellspect permanecerá dentro de la cartera de la Compañía. La Compañía presentó un comunicado de prensa relacionado como Exposición 99.1 en este Current Report en el Formulario 8-K. El registro indica que el anexo se entrega (no se "presenta"), por lo que no se incorpora por referencia en otros documentos del Securities Act o del Exchange Act salvo que se haga una referencia específica. El texto facilitado no incluye estados financieros, términos de la transacción ni proyecciones.
DENTSPLY SIRONA Inc.는 2025년 9월 8일 자사 Wellspect Healthcare 사업에 대한 이전 공개된 전략적 대안 검토를 완료했으며 이사회는 Wellspect가 회사의 포트폴리오에 남을 것이라고 결정했다고 발표했습니다. 회사는 관련 보도자료를 본 8-K 양식 현재보고서의 증빙자료(Exhibit) 99.1로 제출(furnished)했습니다. 제출 서류는 해당 증빙이 '제출(furnished)'되었음을 명시(‘filed’ 아님)하며, 특정한 참조가 없는 한 이를 다른 Securities Act 또는 Exchange Act 문서에 참조로 포함하지 않는다고 밝혔습니다. 제공된 텍스트에는 재무제표, 거래 조건 또는 향후 전망 관련 내용이 포함되어 있지 않습니다.
DENTSPLY SIRONA Inc. a annoncé le 8 septembre 2025 avoir achevé l'examen précédemment annoncé des options stratégiques concernant sa division Wellspect Healthcare et que le Conseil d'administration a décidé que Wellspect restera dans le portefeuille de la Société. La Société a fourni un communiqué de presse connexe en tant qu'Exhibit 99.1 dans ce Current Report sur le Formulaire 8-K. Le dépôt précise que la pièce est fournie ("furnished"), et non "filed", et n'est donc pas incorporée par référence dans d'autres documents en vertu du Securities Act ou de l'Exchange Act sans référence spécifique. Le texte fourni ne contient ni états financiers, ni modalités de transaction, ni projections prospectives.
DENTSPLY SIRONA Inc. gab am 8. September 2025 bekannt, dass die zuvor angekündigte Überprüfung strategischer Alternativen für das Wellspect Healthcare-Geschäft abgeschlossen wurde und der Vorstand entschieden hat, dass Wellspect im Portfolio des Unternehmens verbleiben wird. Das Unternehmen stellte eine zugehörige Pressemitteilung als Exhibit 99.1 in diesem Current Report auf Formular 8-K zur Verfügung. In der Einreichung wird darauf hingewiesen, dass die Anlage "bereitgestellt" (nicht "eingereicht") wurde und daher, sofern nicht ausdrücklich darauf verwiesen, nicht durch Verweisung in andere Unterlagen nach dem Securities Act oder dem Exchange Act aufgenommen wird. Im bereitgestellten Text sind keine Abschlüsse, Transaktionsbedingungen oder zukunftsgerichteten Prognosen enthalten.
- Board decision reached concluding the strategic review, which removes near-term uncertainty over Wellspect’s status
- Press release furnished as Exhibit 99.1, ensuring public disclosure of the Board’s determination
- No financial details provided — the filing does not include valuation, transaction terms, or impact on results
- Exhibit furnished, not filed which limits incorporation by reference into other filings and may reduce legal liability for the disclosed text
Insights
TL;DR: Board concluded divestiture is not pursued; decision preserves current strategic status quo.
The Board’s determination to retain Wellspect indicates management and directors concluded that continuing to own and operate the business fits the company’s strategic objectives or offers greater long-term value than a sale now. Because the filing furnishes a press release and explicitly contains no transaction terms, valuation metrics, or updated financials, the announcement primarily communicates a governance decision rather than a material change in operating results. Investors should note the company withheld further details in this Form 8-K; material financial impact is not disclosed here.
TL;DR: Outcome of strategic review: retention, not disposition; no deal terms disclosed.
The company completed a strategic-alternatives review for Wellspect and decided against a sale or carve-out based on the information provided. The filing only furnishes a press release as Exhibit 99.1 and does not present purchase offers, bidders, valuation ranges, or integration plans. From an M&A perspective, this is a close of a process rather than execution of a transaction; it removes near-term deal risk but does not provide evidence of value realization or cost/synergy outcomes.
DENTSPLY SIRONA Inc. ha annunciato l'8 settembre 2025 di aver completato la revisione delle alternative strategiche per la sua divisione Wellspect Healthcare e il Consiglio ha deciso che Wellspect rimarrà nel portafoglio della Società. La Società ha fornito un comunicato stampa correlato come Allegato 99.1 a questo Current Report sul Modulo 8-K. Nel documento si precisa che l'allegato è "fornito" (non "depositato") e quindi non è incorporato per riferimento in altri documenti ai sensi del Securities Act o dell'Exchange Act, salvo riferimento specifico. Il testo fornito non contiene bilanci, termini della transazione né indicazioni prospettiche.
DENTSPLY SIRONA Inc. anunció el 8 de septiembre de 2025 que completó la revisión previamente comunicada de alternativas estratégicas para su negocio Wellspect Healthcare y la Junta determinó que Wellspect permanecerá dentro de la cartera de la Compañía. La Compañía presentó un comunicado de prensa relacionado como Exposición 99.1 en este Current Report en el Formulario 8-K. El registro indica que el anexo se entrega (no se "presenta"), por lo que no se incorpora por referencia en otros documentos del Securities Act o del Exchange Act salvo que se haga una referencia específica. El texto facilitado no incluye estados financieros, términos de la transacción ni proyecciones.
DENTSPLY SIRONA Inc.는 2025년 9월 8일 자사 Wellspect Healthcare 사업에 대한 이전 공개된 전략적 대안 검토를 완료했으며 이사회는 Wellspect가 회사의 포트폴리오에 남을 것이라고 결정했다고 발표했습니다. 회사는 관련 보도자료를 본 8-K 양식 현재보고서의 증빙자료(Exhibit) 99.1로 제출(furnished)했습니다. 제출 서류는 해당 증빙이 '제출(furnished)'되었음을 명시(‘filed’ 아님)하며, 특정한 참조가 없는 한 이를 다른 Securities Act 또는 Exchange Act 문서에 참조로 포함하지 않는다고 밝혔습니다. 제공된 텍스트에는 재무제표, 거래 조건 또는 향후 전망 관련 내용이 포함되어 있지 않습니다.
DENTSPLY SIRONA Inc. a annoncé le 8 septembre 2025 avoir achevé l'examen précédemment annoncé des options stratégiques concernant sa division Wellspect Healthcare et que le Conseil d'administration a décidé que Wellspect restera dans le portefeuille de la Société. La Société a fourni un communiqué de presse connexe en tant qu'Exhibit 99.1 dans ce Current Report sur le Formulaire 8-K. Le dépôt précise que la pièce est fournie ("furnished"), et non "filed", et n'est donc pas incorporée par référence dans d'autres documents en vertu du Securities Act ou de l'Exchange Act sans référence spécifique. Le texte fourni ne contient ni états financiers, ni modalités de transaction, ni projections prospectives.
DENTSPLY SIRONA Inc. gab am 8. September 2025 bekannt, dass die zuvor angekündigte Überprüfung strategischer Alternativen für das Wellspect Healthcare-Geschäft abgeschlossen wurde und der Vorstand entschieden hat, dass Wellspect im Portfolio des Unternehmens verbleiben wird. Das Unternehmen stellte eine zugehörige Pressemitteilung als Exhibit 99.1 in diesem Current Report auf Formular 8-K zur Verfügung. In der Einreichung wird darauf hingewiesen, dass die Anlage "bereitgestellt" (nicht "eingereicht") wurde und daher, sofern nicht ausdrücklich darauf verwiesen, nicht durch Verweisung in andere Unterlagen nach dem Securities Act oder dem Exchange Act aufgenommen wird. Im bereitgestellten Text sind keine Abschlüsse, Transaktionsbedingungen oder zukunftsgerichteten Prognosen enthalten.
FAQ
What did DENTSPLY SIRONA (XRAY) announce about Wellspect on September 8, 2025?
Does the 8-K include financial terms or sale details for Wellspect?
Is the press release included in the filing legally "filed" with the SEC?
Does this 8-K indicate any change to DENTSPLY SIRONA’s financial reporting or guidance?
What immediate impact does this disclosure have for investors?
